GS7.DE Stock
Price Chart
GS7.DE Financial and Trading Overview
stock price | |
Previous Close | 16.48 |
Open | 16.92 |
Bid | 0 x N/A |
Ask | 0 x N/A |
Day's Range | 16.27 - 20.6 |
52 Week Range | 16.25 - 21.97 |
Volume | 290.93K |
Avg. Volume | 88.64K |
Market Cap | 103.64B |
Beta (5Y Monthly) | 0.253953 |
PE Ratio (TTM) | 17.19324 |
EPS (TTM) | 0 |
Forward Dividend & Yield | 1.11 (5.40%) |
Ex-Dividend Date | May 19, 2022 |
1y Target Est | N/A |
GS7.DE Valuation Measures
Enterprise Value | 129.43B |
Trailing P/E | 17.19324 |
Forward P/E | 0.1844332 |
PEG Ratio (5 yr expected) | 4.08 |
Price/Sales (ttm) | 2.8413947 |
Price/Book (mrq) | 6.932851 |
Enterprise Value/Revenue | 3.548 |
Enterprise Value/EBITDA | 11.965 |
Trading Information
Stock Price History
Beta (5Y Monthly) | 0.253953 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 21.97 |
52 Week Low | 16.25 |
50-Day Moving Average | 20.69 |
200-Day Moving Average | 19.94 |
GS7.DE Share Statistics
Avg. Volume (3 month) | 88.64K |
Avg. Daily Volume (10-Days) | 107.57K |
Shares Outstanding | 5.03B |
Float | 4.89B |
Short Ratio | N/A |
% Held by Insiders | 0.76% |
% Held by Institutions | 44.16% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.8 |
Trailing Annual Dividend Yield | 4.85% |
5 Year Average Dividend Yield | 523.00% |
Payout Ratio | 0.9911 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | March 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 14.01% |
Operating Margin (ttm) | 23.39% |
Gross Margin | 65.29% |
EBITDA Margin | 29.65% |
Management Effectiveness
Return on Assets (ttm) | 6.35% |
Return on Equity (ttm) | 27.51% |
Income Statement
Revenue (ttm) | 36.48B |
Revenue Per Share (ttm) | 7.28 |
Quarterly Revenue Growth (yoy) | 31.80% |
Gross Profit (ttm) | 22.66B |
EBITDA | 10.82B |
Net Income Avi to Common (ttm) | 5.11B |
Diluted EPS (ttm) | 1.198 |
Quarterly Earnings Growth (yoy) | 67.90% |
Balance Sheet
Total Cash (mrq) | 13.98B |
Total Cash Per Share (mrq) | 2.78 |
Total Debt (mrq) | 33.35B |
Total Debt/Equity (mrq) | 147.36 |
Current Ratio (mrq) | 1.194 |
Book Value Per Share (mrq) | 2.971 |
Cash Flow Statement
Operating Cash Flow (ttm) | 10.16B |
Levered Free Cash Flow (ttm) | 7.01B |
Profile of
Country | |
State | N/A |
City | Brentford |
Address | 980 Great West Road |
ZIP | TW8 9GS |
Phone | 44 20 8047 5000 |
Website | https://www.gsk.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 90096 |
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Q&A For Stock
What is a current GS7.DE stock price?
GS7.DE stock price today per share is .
How to purchase stock?
You can buy GS7.DE shares on the exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is GS7.DE.
Which industry does the company belong to?
The industry is Drug Manufacturers-General.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.